Paths of FGFR-driven tumorigenesis

被引：132

作者：

Acevedo, Victor D. ^{[1
,2
]}

Ittmann, Michael ^{[3
]}

Spencer, David M. ^{[1
,2
]}

机构：

[1] Baylor Coll Med, Cell & Mol Biol Program, Houston, TX 77030 USA

[2] Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA

[3] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA

来源：

CELL CYCLE | 2009年 / 8卷 / 04期

关键词：

prostate cancer; fibroblast growth factor receptor (FGFR); chemical inducer of dimerization (CID); epithelial-mesenchymal transition (EMT); angiogenesis; androgen independence; FIBROBLAST-GROWTH-FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; RECEPTOR TYROSINE KINASE; PROSTATE-CANCER; ANDROGEN-RECEPTOR; TUMOR-GROWTH; ENDOTHELIAL-CELLS; INTRAEPITHELIAL NEOPLASIA; TRANSCRIPTION FACTOR; STRUCTURAL BASIS;

D O I：

10.4161/cc.8.4.7657

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Fibroblast growth factor receptors (FGFRs) comprise a subfamily of receptor tyrosine kinases (RTKs) that are master regulators of a broad spectrum of cellular and developmental processes, including apoptosis, proliferation, migration and angiogenesis. Due to their broad impact, FGFRs and other RTKs are highly regulated and normally only basally active. Deregulation of FGFR signaling by activating mutations or ligand/receptor overexpression could allow these receptors to become constitutively active, leading to cancer development, including both hematopoietic and solid tumors, such as breast, bladder and prostate carcinomas. In this review, we focus on potential modes of FGFR-mediated tumorigenesis, in particular, the role of FGFR1 during prostate cancer progression.

引用

页码：580 / 588

页数：9

共 123 条

[1]

Abate-Shen C, 2003, CANCER RES, V63, P3886

[2] Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition [J].

Acevedo, Victor D. ;

Gangula, Rama D. ;

Freeman, Kevin W. ;

Li, Rile ;

Zhang, Youngyou ;

Wang, Fen ;

Ayala, Gustavo E. ;

Peterson, Leif E. ;

Ittmann, Michael ;

Spencer, David M. .

CANCER CELL, 2007, 12 (06) :559-571

[3] Prospective identification of tumorigenic breast cancer cells [J].

Al-Hajj, M ;

Wicha, MS ;

Benito-Hernandez, A ;

Morrison, SJ ;

Clarke, MF .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3983-3988

[4] Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence [J].

Ansieau, Stephane ;

Bastid, Jeremy ;

Doreau, Agnes ;

Morel, Anne-Pierre ;

Bouchet, Benjamin P. ;

Thomas, Clemence ;

Fauvet, Frederique ;

Puisieux, Isabelle ;

Doglioni, Claudio ;

Piccinin, Sara ;

Maestro, Roberta ;

Voeltzel, Thibault ;

Selmi, Abdelkader ;

Valsesia-Wittmann, Sandrine ;

de Fromentel, Claude Caron ;

Puisieux, Alain .

CANCER CELL, 2008, 14 (01) :79-89

[5]

Auguste P, 2001, CANCER RES, V61, P1717

[6] Tumorigenesis and the angiogenic switch [J].

Bergers, G ;

Benjamin, LE .

NATURE REVIEWS CANCER, 2003, 3 (06) :401-410

[7] The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions:: a comparison with Snail and E47 repressors [J].

Bolós, V ;

Peinado, H ;

Pérez-Moreno, MA ;

Fraga, MF ;

Esteller, M ;

Cano, A .

JOURNAL OF CELL SCIENCE, 2003, 116 (03) :499-511

[8] Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas [J].

Cappellen, D ;

De Oliveira, C ;

Ricol, D ;

de Medina, SGD ;

Bourdin, J ;

Sastre-Garau, X ;

Chopin, D ;

Thiery, JP ;

Radvanyi, F .

NATURE GENETICS, 1999, 23 (01) :18-20

[9] Alternative splicing of fibroblast growth factor receptor 2 (FGF-R2) in human prostate cancer [J].

Carstens, RP ;

Eaton, JV ;

Krigman, HR ;

Walther, PJ ;

Garcia-Blanco, MA .

ONCOGENE, 1997, 15 (25) :3059-3065

[10] The transcriptional control of trunk neural crest induction, survival, and delamination [J].

Cheung, M ;

Chaboissier, MC ;

Mynett, A ;

Hirst, E ;

Schedl, A ;

Briscoe, J .

DEVELOPMENTAL CELL, 2005, 8 (02) :179-192

← 1 2 3 4 5 6 7 8 9 10 →